Literature DB >> 16373523

What's in a name? Embryos, entities, and ANTities in the stem cell debate.

K Devolder1.   

Abstract

This paper discusses two proposals to the US President's Council on Bioethics that try to overcome the issue of killing embryos in embryonic stem (ES) cell research and argues that neither of them can hold good as a compromise solution. The author argues that (1) the groups of people for which the compromises are intended neither need nor want the two compromises, (2) the US government and other governments of countries with restrictive regulation on ES cell research have not provided a clear and sound justification to take into account minority views on the protection of human life to such a considerable extent as to constrain the freedom of research in the area of stem cell research, and (3) the best way to deal with these issues is to accept that many people and most governments adopt a gradualist and variable viewpoint on the human embryo which implies that embryos can be sacrificed for good reasons and to try to find other, less constraining, ways to take into account minority views on the embryo. Finally, another more efficient and time and money sparing compromise will be proposed for those who accept IVF, a majority in most societies.

Entities:  

Mesh:

Year:  2006        PMID: 16373523      PMCID: PMC2563266          DOI: 10.1136/jme.2005.012203

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  19 in total

1.  An ethical defense of federal funding for human embryonic stem cell research.

Authors:  J F Childress
Journal:  Yale J Health Policy Law Ethics       Date:  2001

2.  Scientific freedom and research cloning: can a ban be justified?

Authors:  Timothy Caulfield
Journal:  Lancet       Date:  2004 Jul 10-16       Impact factor: 79.321

3.  Clinical challenges in providing embryos for stem-cell initiatives.

Authors:  Christopher L R Barratt; Justin C St John; Masoud Afnan
Journal:  Lancet       Date:  2004 Jul 10-16       Impact factor: 79.321

Review 4.  Embryonic death and the creation of human embryonic stem cells.

Authors:  Donald W Landry; Howard A Zucker
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

5.  Altered nuclear transfer in stem-cell research - a flawed proposal.

Authors:  Douglas A Melton; George Q Daley; Charles G Jennings
Journal:  N Engl J Med       Date:  2004-12-30       Impact factor: 91.245

6.  Human therapeutic cloning.

Authors:  R P Lanza; J B Cibelli; M D West
Journal:  Nat Med       Date:  1999-09       Impact factor: 53.440

7.  Human embryonic stem cell research: why the discarded-created-distinction cannot be based on the potentiality argument.

Authors:  Katrien Devolder
Journal:  Bioethics       Date:  2005-04       Impact factor: 1.898

8.  Human embryonic stem cells and respect for life.

Authors:  J R Meyer
Journal:  J Med Ethics       Date:  2000-06       Impact factor: 2.903

9.  The ethics of funding embryonic stem cell research: a Catholic viewpoint.

Authors:  Richard M Doerflinger
Journal:  Kennedy Inst Ethics J       Date:  1999-06

10.  Transgenic bovine chimeric offspring produced from somatic cell-derived stem-like cells.

Authors:  J B Cibelli; S L Stice; P J Golueke; J J Kane; J Jerry; C Blackwell; F A Ponce de León; J M Robl
Journal:  Nat Biotechnol       Date:  1998-07       Impact factor: 54.908

View more
  3 in total

1.  The ethics of moral compromise for stem cell research policy.

Authors:  Zubin Master; G K D Crozier
Journal:  Health Care Anal       Date:  2012-03

Review 2.  How and Why to Replace the 14-Day Rule.

Authors:  Sarah Chan
Journal:  Curr Stem Cell Rep       Date:  2018-07-16

3.  The problems with forbidding science.

Authors:  Gary E Marchant; Lynda L Pope
Journal:  Sci Eng Ethics       Date:  2009-04-07       Impact factor: 3.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.